A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.

NCT00616798 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

323

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: RO4917838
DRUG: RO4917838
DRUG: RO4917838
DRUG: Placebo
DRUG: Standard antipsychotic therapy

Sponsor

Hoffmann-La Roche